• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用微量超速离心法评估药物的蛋白结合率。

Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method.

作者信息

Nakai Daisuke, Kumamoto Kazuyo, Sakikawa Chisa, Kosaka Toshiyuki, Tokui Taro

机构信息

Pharmacokinetics and Drug Delivery Research Laboratories, Sankyo Company, Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.

出版信息

J Pharm Sci. 2004 Apr;93(4):847-54. doi: 10.1002/jps.20012.

DOI:10.1002/jps.20012
PMID:14999723
Abstract

Ultracentrifugation methods have been widely used for the determination of the free fraction of compounds in plasma, especially for lipophilic compounds. To estimate the effect of contaminated proteins in the "protein-free phase" fraction, 200 microL of human plasma was separated into three layers by ultracentrifugation at 436,000g for 140 min with a table-top ultracentrifuge. Twenty microliters of the middle layer was taken as the protein-free fraction. Major contaminated proteins were analyzed by liquid chromatography/electrospray ionization/tandem mass spectrometry (LC/ESI/MS/MS) and identified as albumin, alpha-1-antitrypsin, alpha-2-HS-glycoprotein, apolipoprotein E, and apolipoprotein A-1. alpha-1-acid glycoprotein was not detected. Contamination of albumin was 0.13% of that in plasma. Simulation analysis demonstrated that at an actual free fraction of 1% (protein binding ratio of 99%), the extent of overestimation of free fraction was just 13% and the apparent free fraction was 1.13%. Human plasma protein binding ratios of 10 drugs estimated by this method correlated well with reported values determined by other methods, such as ultrafiltration and equilibrium dialysis, with a correlation factor of 0.98 and a slope of 0.99. Collectively, our results indicate the reliability of this micro-scale ultracentrifugation technique for the evaluation of the protein binding of drugs despite a little contamination of albumin.

摘要

超速离心法已被广泛用于测定血浆中化合物的游离分数,尤其是亲脂性化合物。为了评估“无蛋白相”部分中污染蛋白质的影响,使用台式超速离心机在436,000g下超速离心140分钟,将200微升人血浆分离成三层。取中间层的20微升作为无蛋白部分。通过液相色谱/电喷雾电离/串联质谱(LC/ESI/MS/MS)分析主要污染蛋白质,并鉴定为白蛋白、α-1-抗胰蛋白酶、α-2-HS-糖蛋白、载脂蛋白E和载脂蛋白A-1。未检测到α-1-酸性糖蛋白。白蛋白的污染量为血浆中白蛋白量的0.13%。模拟分析表明,在实际游离分数为1%(蛋白结合率为99%)时,游离分数的高估程度仅为13%,表观游离分数为1.13%。用该方法估算的10种药物的人血浆蛋白结合率与超滤和平衡透析等其他方法测定的报道值相关性良好,相关系数为0.98,斜率为0.99。总体而言,我们的结果表明,尽管存在少量白蛋白污染,这种微量超速离心技术在评估药物蛋白结合方面是可靠的。

相似文献

1
Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method.采用微量超速离心法评估药物的蛋白结合率。
J Pharm Sci. 2004 Apr;93(4):847-54. doi: 10.1002/jps.20012.
2
Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination.使用未标记化合物的盒式超速离心法结合液相色谱-串联质谱分析法进行高通量蛋白质结合测定
J Pharm Sci. 2016 Mar;105(3):1036-42. doi: 10.1016/S0022-3549(15)00177-X. Epub 2016 Jan 27.
3
Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.药物蛋白结合测定方法的评估。平衡透析、超滤、超速离心、凝胶过滤。
Arzneimittelforschung. 1977 Jul;27(7):1373-80.
4
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
5
Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.用非放射性化合物的平衡凝胶过滤和 LC-MS/MS 检测测定高度结合药物的血浆蛋白结合率。
J Pharm Sci. 2019 Feb;108(2):1053-1060. doi: 10.1016/j.xphs.2018.10.004. Epub 2018 Oct 16.
6
Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry.运用超速离心和 UPLC-串联质谱法进行体外和体内血浆蛋白结合的相关性研究。
Analyst. 2013 Oct 21;138(20):6106-16. doi: 10.1039/c3an01116j. Epub 2013 Aug 21.
7
Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.采用电喷雾电离质谱和低能量碰撞诱导解离串联质谱对药用级人血清白蛋白的半胱氨酸化进行表征。
Rapid Commun Mass Spectrom. 2005;19(20):2965-73. doi: 10.1002/rcm.2154.
8
Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES.与使用羟乙基淀粉进行容量替代相比,输注白蛋白可减轻外科手术患者药物血清蛋白结合的变化。
Acta Anaesthesiol Scand. 2008 Mar;52(3):406-12. doi: 10.1111/j.1399-6576.2007.01555.x.
9
Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.平衡凝胶过滤法测定与蛋白高度结合的药物的血浆蛋白结合率。
J Pharm Sci. 2014 Feb;103(2):752-9. doi: 10.1002/jps.23818. Epub 2013 Dec 20.
10
Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.电喷雾电离质谱法作为通过非共价相互作用测定药物与人血清白蛋白结合位点的工具。
Rapid Commun Mass Spectrom. 2005;19(12):1637-43. doi: 10.1002/rcm.1967.

引用本文的文献

1
Streamlining Linear Free Energy Relationships of Proteins through Dimensionality Analysis and Linear Modeling.通过维度分析和线性建模简化蛋白质的线性自由能关系
J Chem Inf Model. 2024 Dec 23;64(24):9327-9340. doi: 10.1021/acs.jcim.4c01289. Epub 2024 Dec 2.
2
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.靶向双重氨肽酶抑制作用提供跨物种抗疟活性。
mBio. 2024 Jun 12;15(6):e0096624. doi: 10.1128/mbio.00966-24. Epub 2024 May 8.
3
Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.
全氟及多氟烷基物质基于类别毒代动力学评估的血浆蛋白结合评估。
Chem Res Toxicol. 2023 Jun 19;36(6):870-881. doi: 10.1021/acs.chemrestox.3c00003. Epub 2023 May 15.
4
Dosing Methods to Enable Cell-Based In Vitro Testing of Complex Substances: A Case Study with a PAH Mixture.实现复杂物质基于细胞的体外测试的给药方法:以多环芳烃混合物为例的案例研究
Toxics. 2022 Dec 26;11(1):19. doi: 10.3390/toxics11010019.
5
Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.翻译抗菌药物研发中的蛋白质结合——关注种间差异
Antibiotics (Basel). 2022 Jul 8;11(7):923. doi: 10.3390/antibiotics11070923.
6
Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.白蛋白介导摄取改善了用于预测肝摄取转运体底物的人体清除率,有助于在发现研究中建立基于机制的体外-体内外推(IVIVE)策略。
AAPS J. 2020 Nov 16;23(1):1. doi: 10.1208/s12248-020-00528-y.
7
An in vitro toolbox to accelerate anti-malarial drug discovery and development.一种加速抗疟药物发现和开发的体外工具包。
Malar J. 2020 Jan 2;19(1):1. doi: 10.1186/s12936-019-3075-5.
8
Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors.胃肠道间质瘤患者中基因多态性与未结合伊马替尼及其活性代谢产物浓度的不良事件
Front Pharmacol. 2019 Jul 30;10:854. doi: 10.3389/fphar.2019.00854. eCollection 2019.
9
Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds.在 Caco-2 研究中使用人血浆作为检测介质可改善亲脂性化合物的质量平衡。
Pharm Res. 2018 Sep 17;35(11):210. doi: 10.1007/s11095-018-2493-3.
10
An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.探讨与体外-体内外推相关的蛋白结合和蛋白促进摄取。
Eur J Pharm Sci. 2018 Oct 15;123:502-514. doi: 10.1016/j.ejps.2018.08.008. Epub 2018 Aug 8.